Transcription of Neonatal Abstinence Syndrome (NAS) - kemh.health.wa.gov.au
{{id}} {{{paragraph}}}
Example: biology
Neonatal Abstinence Syndrome (NAS) - kemh.health.wa.gov.au
Women and Newborn Health Service Neonatal Directorate CLINICAL PRACTICE GUIDELINE. Guideline coverage includes NICU KEMH, NICU PCH and NETS WA. Neonatal Abstinence Syndrome (NAS). This document should be read in conjunction with the Disclaimer Contents Background ..2. Assessment and Care After Birth ..4. Non-Pharmacological Interventions ..5. Pharmacological Treatment ..6. Discharge Planning .. 10. Home Medication Management Program..11. NAS Scoring Instructions 12. References ..14. Page 1 of 14. Neonatal Abstinence Syndrome (NAS). Background Maternal drug use is a risk factor for adverse pregnancy and Neonatal outcomes including preterm birth. Infants born to mothers using illicit drugs, apart from Neonatal drug withdrawal, are at risk of adverse Neonatal outcomes. All women using drugs are entitled to accurate information, and to be treated sensitively and in a non- judgmental manner. Neonatal Abstinence Syndrome is a generalised disorder presenting a clinical picture of drug withdrawal in the infant.
Neonatal Abstinence Syndrome (NAS) Page 6 of 15 Neonatal Directorate symptoms, adequacy of feeding, adequacy of weight gain (or severity of weight loss) and non-pharmacological interventions.
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: